Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02299518
Title Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bhavana Bhatnagar
Indications

acute myeloid leukemia

Therapies

Etoposide

Selinexor

Cytarabine + Etoposide + Mitoxantrone

Age Groups: adult
Covered Countries USA


No variant requirements are available.